Tobacco Harm Reduction

Cigarette smoking remains the leading cause of preventable premature death and disease. From conventional cigarettes to non-combustible alternatives, at ABF we help to understand the continuum of risk associated with nicotine-containing products. Our validated bioanalytical methods provide reliable data for regulatory submissions.
Request now
tobacco

Expert Bioanalytical Services for Regulated Biomarker Studies

Nicotine Pharmacokinetic Analysis for Regulatory Submissions

Trusted Bioanalytical Services Tailored to Your Specific Application

Integrated Solutions for Seamless Sample Management World Wide

Do you have any questions about our services?

We would be happy to advise and support you with your project or your study. Send us your request and tell us your specific wishes.

Pioneers in biomarker research

Almost all of the biomarker methods developed at ABF were published in peer-reviewed journals, a fact that supports the validity, transparency and scientific evidence of the bioanalysis especially of importance for regulatory submissions